Mirae Asset Global ETFs Holdings
XFOR icon

Mirae Asset Global ETFs Holdings’s X4 Pharmaceuticals XFOR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Buy
+37,073
New +$152K ﹤0.01% 2561
2025
Q2 		– Sell
-3,356
Closed -$23.8K – 3263
2025
Q1 		$23.8K Buy
3,356
+143
+4% +$1.97K ﹤0.01% 2965
2024
Q4 		$70.7K Buy
3,213
+137
+4% +$2.18K ﹤0.01% 2826
2024
Q3 		$61.8K Buy
3,076
+961
+45% +$20.1K ﹤0.01% 2876
2024
Q2 		$36.8K Buy
+2,115
New +$69.2K ﹤0.01% 2850

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mirae Asset Global ETFs Holdings's XFOR Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in X4 Pharmaceuticals (XFOR) in Q2 2026: 37,073 shares worth $173K. The stake represents ﹤0.01% of the portfolio and ranks #2561 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in XFOR as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in XFOR in Q2 2024 and has held it in 5 quarters since. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 37,073 shares of X4 Pharmaceuticals worth $173K as of Q2 2026.
  • X4 Pharmaceuticals was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2561 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in X4 Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.